Thannickal Victor J, Toews Galen B, White Eric S, Lynch Joseph P, Martinez Fernando J
Division of Pulmonary and Critical Care Medicine, University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA.
Annu Rev Med. 2004;55:395-417. doi: 10.1146/annurev.med.55.091902.103810.
Tissue injury evokes highly conserved, tightly regulated inflammatory responses and less well-understood host repair responses. Both inflammation and repair involve the recruitment, activation, apoptosis, and eventual clearance of key effector cells. In this review, we propose the concept of pulmonary fibrosis as a dysregulated repair process that is perpetually "turned on" even though classical inflammatory pathways may be dampened or "switched off." Significant regional heterogeneity, with varied histopathological patterns of inflammation and fibrosis, has been observed in individual patients with idiopathic pulmonary fibrosis. We discuss environmental factors and host response factors, such as genetic susceptibility and age, that may influence these varied manifestations. Better understanding of the mechanisms of lung repair, which include alveolar reepithelialization, myofibroblast differentiation/activation, and apoptosis, should offer more effective therapeutic options for progressive pulmonary fibrosis.
组织损伤会引发高度保守、严格调控的炎症反应以及人们了解较少的宿主修复反应。炎症和修复都涉及关键效应细胞的募集、激活、凋亡以及最终清除。在本综述中,我们提出肺纤维化是一种失调的修复过程这一概念,即即便经典炎症途径可能受到抑制或“关闭”,该修复过程仍持续“开启”。在特发性肺纤维化个体患者中已观察到显著的区域异质性,伴有炎症和纤维化的不同组织病理学模式。我们讨论了可能影响这些不同表现的环境因素和宿主反应因素,如遗传易感性和年龄。更好地理解肺修复机制,包括肺泡再上皮化、肌成纤维细胞分化/激活和凋亡,应为进行性肺纤维化提供更有效的治疗选择。